<DOC>
	<DOCNO>NCT01378715</DOCNO>
	<brief_summary>The aim study determine whether pre-treatment high-dose statin ( one day prior intervention , rosuvastatin 20mg/day ) positive impact occurrence periprocedural myocardial infarction percutaneous coronary intervention ( PCI ) .</brief_summary>
	<brief_title>Rosuvastatin Pre-Treatment Influences Risk Coronary Intervention Study</brief_title>
	<detailed_description>The aim study attest whether short-term treatment high-dose statin ( one day prior intervention , rosuvastatin 20mg/day ) positive impact occurrence periprocedural myocardial infarction percutaneous coronary intervention ( PCI ) . Patients stable unstable ( negative troponin ) angina pectoris receive statin ( , except rosuvastatin 40mg day ) therapy refer coronary angiography subsequently PCI enrol randomize ( ratio 1:1 ) pre-treatment rosuvastatin ( 20mg 12 hour prior + 20mg immediately PCI - Rosuvastatin group ) , immediate PCI ( control group ) . Serum concentration troponin I measure prior , 12 hour 24 hour PCI . Power study ( 200 vs 200 pt ; p1 = 0.2 ; p2 = 0.33 ; alfa = 0.05 , n1 = 200 , n2 = 200 ; power 0.84 ) . The primary end-point TnI concentration ≥ 1.5 time ULN . The secondary end-point witl TnI concentration ≥ 3 time ULN . The Cox regression model use identify predictor primary end-points ( age , diabetes , smoking , symptomatic peripheral artery disease , statin pre-treatment , level total cholesterol , pre-treatment clopidogrel , multi-vessel disease , unstable angina , hs-CRP , therapy beta-blockers , treatment complex coronary lesion ) . The patient include shall fulfill criterion : 1 ) significant coronary artery stenosis occlusion indicate percutaneous coronary intervention 2 ) sign informed consent . The criterion exclude inclusion study : 1 ) positive troponin I ( ≥ 1 ULN ) , 2 ) previous inclusion study , 3 ) renal insufficiency , 4 ) chronic treatment rosuvastatin 40mg , 5 ) disagreement include study . This study multicenter . The Motol University Hospital participate project coordinator .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>significant coronary artery stenosis occlusion indicate percutaneous coronary intervention sign informed consent positive troponin I ( ≥ 1 ULN ) previous inclusion study renal insufficiency ( creatinine ≥ 200 umol/l ) chronic treatment rosuvastatin 40mg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>coronary artery disease</keyword>
	<keyword>percutaneous coronary intervention</keyword>
	<keyword>statin</keyword>
	<keyword>periprocedural myocardial infarction</keyword>
</DOC>